The PBC Ireland patient registry: study protocol for a national platform on primary biliary cholangitis.

Therapeutic advances in rare disease Pub Date : 2026-02-28 eCollection Date: 2026-01-01 DOI:10.1177/26330040261427491
Gerry Nesbitt, Alexandra Curley
{"title":"The PBC Ireland patient registry: study protocol for a national platform on primary biliary cholangitis.","authors":"Gerry Nesbitt, Alexandra Curley","doi":"10.1177/26330040261427491","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary Biliary Cholangitis (PBC) is a chronic, progressive liver disease. This paper outlines how a PBC patient registry was developed to address the gaps in evidence, care and policy affecting PBC patients in Ireland.</p><p><strong>Objectives: </strong>The PBC patient registry is designed to collect patient-reported data regarding medical history, pruritus, fatigue and quality of life of PBC patients living in Ireland. This data can be used to identify care and treatment gaps and ensure that the PBC patient voice is included in new treatment decisions and healthcare policy. This real-world data will support further scientific and clinical research, drive patient-led advocacy efforts and facilitate collaboration with the liver disease communities globally.</p><p><strong>Design: </strong>A patient-led, observational, registry-based study of PBC patients in Ireland.</p><p><strong>Methods and analysis: </strong>Participants must have a PBC diagnosis and be 18 years of age or older. PROMs (patient-reported outcome measures) were administered through a secure web-based system. After providing electronic informed consent, participants completed online data collection forms. These included demographic information, medical history, standard of care and validated PROMs for fatigue, pruritus and quality of life. This was followed by an anonymous survey to collect usability and comprehensiveness metadata.</p><p><strong>Ethics: </strong>The protocol was approved by TIER IRB Services, protocol ID: 5250715 (July 18th, 2025), which determined the study to be exempt as an observational, minimal-risk, non-interventional research activity involving anonymised patient-reported data.</p><p><strong>Discussion: </strong>At the time of publication, 52 participants were registered in the patient registry, of which 40 completed all data collection forms. The results of the post-completion survey suggest high satisfaction across the domains of usability, comprehension, relevance, privacy/confidentiality and overall experience. The PBC patient registry shows that web-based PROMs can be used to collect real-world evidence from patients. Participants reported that the system was easy to use and comprehensive, confirming the usability and effectiveness of this approach. It also provides a starting point to identify healthcare and treatment gaps and facilitates the inclusion of PBC patients' voices in national and international health policy decisions that affect them.</p><p><strong>Trial registration: </strong>Not applicable.</p>","PeriodicalId":75218,"journal":{"name":"Therapeutic advances in rare disease","volume":"7 ","pages":"26330040261427491"},"PeriodicalIF":0.0000,"publicationDate":"2026-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12954011/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic advances in rare disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26330040261427491","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Primary Biliary Cholangitis (PBC) is a chronic, progressive liver disease. This paper outlines how a PBC patient registry was developed to address the gaps in evidence, care and policy affecting PBC patients in Ireland.

Objectives: The PBC patient registry is designed to collect patient-reported data regarding medical history, pruritus, fatigue and quality of life of PBC patients living in Ireland. This data can be used to identify care and treatment gaps and ensure that the PBC patient voice is included in new treatment decisions and healthcare policy. This real-world data will support further scientific and clinical research, drive patient-led advocacy efforts and facilitate collaboration with the liver disease communities globally.

Design: A patient-led, observational, registry-based study of PBC patients in Ireland.

Methods and analysis: Participants must have a PBC diagnosis and be 18 years of age or older. PROMs (patient-reported outcome measures) were administered through a secure web-based system. After providing electronic informed consent, participants completed online data collection forms. These included demographic information, medical history, standard of care and validated PROMs for fatigue, pruritus and quality of life. This was followed by an anonymous survey to collect usability and comprehensiveness metadata.

Ethics: The protocol was approved by TIER IRB Services, protocol ID: 5250715 (July 18th, 2025), which determined the study to be exempt as an observational, minimal-risk, non-interventional research activity involving anonymised patient-reported data.

Discussion: At the time of publication, 52 participants were registered in the patient registry, of which 40 completed all data collection forms. The results of the post-completion survey suggest high satisfaction across the domains of usability, comprehension, relevance, privacy/confidentiality and overall experience. The PBC patient registry shows that web-based PROMs can be used to collect real-world evidence from patients. Participants reported that the system was easy to use and comprehensive, confirming the usability and effectiveness of this approach. It also provides a starting point to identify healthcare and treatment gaps and facilitates the inclusion of PBC patients' voices in national and international health policy decisions that affect them.

Trial registration: Not applicable.

Abstract Image

Abstract Image

Abstract Image

PBC爱尔兰患者登记:原发性胆管炎国家平台的研究方案。
背景:原发性胆道胆管炎(PBC)是一种慢性进行性肝脏疾病。本文概述了如何开发PBC患者登记,以解决影响爱尔兰PBC患者的证据,护理和政策方面的差距。目的:PBC患者登记旨在收集患者报告的有关居住在爱尔兰的PBC患者的病史、瘙痒、疲劳和生活质量的数据。这些数据可用于确定护理和治疗差距,并确保将PBC患者的意见纳入新的治疗决策和医疗保健政策。这些真实数据将支持进一步的科学和临床研究,推动以患者为主导的倡导工作,并促进与全球肝病社区的合作。设计:一项以患者为主导、观察性、登记为基础的爱尔兰PBC患者研究。方法和分析:参与者必须有PBC诊断,年龄在18岁以上。PROMs(患者报告的结果测量)通过安全的基于网络的系统进行管理。在提供电子知情同意书后,参与者填写在线数据收集表格。这些包括人口统计信息、病史、护理标准和疲劳、瘙痒和生活质量的有效PROMs。随后进行了一项匿名调查,以收集可用性和全面性元数据。伦理:该方案经TIER IRB Services批准,方案ID: 5250715(2025年7月18日),确定该研究作为一项涉及匿名患者报告数据的观察性、最低风险、非干预性研究活动获得豁免。讨论:在发表时,52名参与者在患者登记处登记,其中40人完成了所有数据收集表格。完成后的调查结果表明,在可用性、理解性、相关性、隐私/机密性和整体体验方面,用户都非常满意。PBC患者登记表明,基于网络的prom可用于从患者那里收集真实世界的证据。与会者报告说,该系统易于使用和全面,证实了这种方法的可用性和有效性。它还提供了一个起点,以确定保健和治疗差距,并促进将PBC患者的声音纳入影响他们的国家和国际卫生政策决定。试验注册:不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书